Alberto Mendez
Kissimmee, FLNPI 1679503452
Payments from drug & device makers
$1,788in general payments, 2019–2025
Across 120 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$392
- Medtronic$249
- Amgen$213
- AbbVie$212
- Lilly USA, LLC$170
- Sanofi-aventis U.S. LLC$108
- plus $445 from 15 others
What the payments were for
- Food & beverage$1,788100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $392 |
| Medtronic | 28 | $249 |
| Amgen | 12 | $213 |
| AbbVie(2 entities) | 13 | $212 |
| Lilly USA, LLC | 10 | $170 |
| Sanofi-aventis U.S. LLC | 6 | $108 |
| Insulet Corporation | 3 | $58 |
| Boehringer Ingelheim | 3 | $58 |
| AstraZeneca(2 entities) | 3 | $56 |
| Abbott | 3 | $46 |
| IBSA Pharma Inc. | 3 | $37 |
| Merck | 2 | $28 |
| Chiesi USA, Inc. | 1 | $25 |
| Mannkind Corporation | 1 | $21 |
| Radius Health, Inc. | 1 | $20 |
| Tandem Diabetes Care, Inc. | 1 | $19 |
| Companion Medical, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Acerus Pharmaceuticals Corporation | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.